Physician profile
Douglas Mathew Sidle
NPI 1730179482
$327,719.29
in general payments reported to CMS, 2019-2025
12 companies · $1,520 in 2025
The $1,520 reported for 2025 was more than what 91% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $15K · 2021: $1,339 · 2022: $189K · 2023: $2,140 · 2024: $2,478 · 2025: $1,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,137.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $180,381.00 | 2022 | |
| Stryker Corporation | $140,419.76 | 2019-2025 | Na, Smartlock |
| Aerin Medical INC. | $2,710.11 | 2021-2025 | |
| Integra Lifesciences Corporation | $1,248.38 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $851.37 | 2023-2025 | Puraply, Via Matrix, Puraply Franchise |
| Axogen | $597.47 | 2023 | Avance Nerve Graft |
| Depuy Synthes Sales INC. | $405.83 | 2020-2025 | Trumatch, Matrixmandible |
| Abbvie INC. | $306.11 | 2024-2025 | |
| Spirair, INC. | $256.08 | 2024 | Septalign |
| Regeneron Healthcare Solutions, INC. | $223.02 | 2023-2024 | Dupixent |
| Smith+Nephew, INC. | $175.45 | 2023 | Stravix, Grafix Pl, Stravix Pl |
| Medtronic, INC. | $144.71 | 2024 | Novapak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Sidle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.